AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Replikun Biotech Pty Ltd. develops vector delivery system for vaccines and gene therapy. It offers preventative and therapeutic vaccines for intractable infections and cancer. The company was founded in March 2005 and is headquartered in Toowong, Australia

Denka Corp., part of Denka Co., Ltd., is an American company located in New York, NY. The firm manufactures and distributes chemical products.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Henan Academy of Agricultural Sciences is a Chinese private company located in Zhengzhou. The firm engages in publishing and printing, books and pamphlets.

Tianjin International Biomedical Joint Research Institute Co., Ltd., established on 2010-05-18, Business scope includes scientific and technological research and development and related consulting;Biotechnology R&D and Application;R&D and pilot test of pharmaceutical products,analysis test,Technical Services,information service;Financing Consulting;Business Consulting;House to rent;financial services;Tax agency service;Conference Services;Technology intermediary service;Daily necessities,Wholesale and retail of experimental instruments;laboratory equipment(Does not contain medical devices)research and development,Sales;laboratory materials(Does not contain food,medicine,Hazardous Chemicals and Precursors)promotion of;Wholesale and retail of prepackaged food;Entrusted to provide business services for enterprises.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Weirui Biotechnology Co., Ltd., established on 2014-07-09, Business scope includes licensed projects:Production of Class II Medical Devices[Branch operation];Production of Class III Medical Devices[Branch operation];Veterinary drug production[Branch operation];Class III medical device business;Veterinary drug business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Retailing of computer software, hardware and auxiliary equipment;Instrument Manufacturing[Branch operation];Instrument sales;Technology Import and Export;Import and export;Production of Class I Medical Devices[Branch operation].(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary next generation i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland

Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Enzyme immunoassay method, Gene amplification diagnosis, Rapid diagnosis and Raw materials. The Enzyme immunoassay method business division offers enzyme-linked immunosorbent assay for bovine, swine and poultry. The Gene amplification diagnosis business division provides polymerase chain reaction kits. The Rapid diagnosis business division offers rapid kits such as companion animals rapid kit, livestock and poultry animals rapid kit. The Raw materials business division provides biologicals such anti-hemoglobin, malaria plasmodium and anti-malaria. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.

Cardiovention, Inc. manufactures cardiovascular equipment. The firm develops, manufactures, and markets circulatory support system that offers clinicians the opportunity to deliver high-quality medical care. The company was founded by Thomas A. Afzal and is located in Santa Clara, CA.

Viagene is a life science business that was started by researchers with a wealth of knowledge in the biological sciences. It is dedicated to achieving its business objective of contributing to the advancement of molecular and cell biology research across the globe by offering creative, practical, and accessible products and services. The company's main goal is to provide inventive methods and new goods to advance life science research.

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.

Tokyo Metropolitan Institute of Medical Science is a Japanese private company. The firm operates as a research institute that develops medicine.